BIBLIOGRAPHIC RECORD

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Colleen Loo; Nick Glozier; Dávid Barton; Bernhard T. Baune; Natalie Mills; Paul B. Fitzgerald; Paul Glue; Shanthi Sarma; Verònica Gálvez-Ortiz; Dušan Hadži-Pavlović; Angelo Alonzo; Vanessa Dong; Donel Martin; Stevan Nikolin; Philip B. Mitchell; Michael Berk; Gregory Carter; Maree L. Hackett; John Leyden; Sean Hood; Andrew A. Somogyi; Kyle Lapidus; Elizabeth Stratton; Kirsten Gainsford; Deepak Garg; Nicollette Thornton; Célia Fourrier; Karyn Richardson; Demi Rozakis; Anish Scaria
Source of metadata
OpenAlex
Year recorded
2023

Public identifiers and source

Open the source record

Reference

Colleen Loo; Nick Glozier; Dávid Barton; Bernhard T. Baune; Natalie Mills; Paul B. Fitzgerald; Paul Glue; Shanthi Sarma; Verònica Gálvez-Ortiz; Dušan Hadži-Pavlović; Angelo Alonzo; Vanessa Dong; Donel Martin; Stevan Nikolin; Philip B. Mitchell; Michael Berk; Gregory Carter; Maree L. Hackett; John Leyden; Sean Hood; Andrew A. Somogyi; Kyle Lapidus; Elizabeth Stratton; Kirsten Gainsford; Deepak Garg; Nicollette Thornton; Célia Fourrier; Karyn Richardson; Demi Rozakis; Anish Scaria. (2023). Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial. https://openalex.org/W4384153740

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-b175afe91974b6726f4b77dd87babb46/